Immunotherapy for pulmonary squamous cell carcinoma and colon carcinoma with pembrolizumab: A case report

RATIONALE: Novel treatment strategies such as immunotherapy are being evaluated to further improve the outcomes of colorectal cancer patients. To our knowledge, this is the first report to show both the successful treatment of pulmonary squamous cell carcinoma (SCC) with pembrolizumab alongside hist...

Descripción completa

Detalles Bibliográficos
Autores principales: Nozawa, Yoshihiro, Oka, Yuka, Oosugi, Jun, Takemura, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959407/
https://www.ncbi.nlm.nih.gov/pubmed/29742733
http://dx.doi.org/10.1097/MD.0000000000010718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959407/
https://www.ncbi.nlm.nih.gov/pubmed/29742733
http://dx.doi.org/10.1097/MD.0000000000010718

Ejemplares similares